Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Introduction
Thank you for your participation in the FASTEST Trial.
The following presentation will provide you with the necessary background and information necessary for successful patient enrolment and scan interpretation.
The presentation is followed by a short quiz that is required for trial involvement. Website registration is required.